Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons.
Fingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons.
复制标题
DOI:
10.1371/journal.pone.0061988
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Suzumura A
中科院分区:
文献类型:
--
作者:
Doi Y;Takeuchi H;Horiuchi H;Hanyu T;Kawanokuchi J;Jin S;Parajuli B;Sonobe Y;Mizuno T;Suzumura A
The neurodegenerative processes that underlie Alzheimer's disease are mediated, in part, by soluble oligomeric amyloid β, a neurotoxic protein that inhibits hippocampal long-term potentiation, disrupts synaptic plasticity, and induces the production of reactive oxygen species. Here we show that the sphingosine-1-phosphate (S1P) receptor (S1PR) agonist fingolimod phosphate (FTY720-P)-a new oral drug for multiple sclerosis-protects neurons against oligomeric amyloid β-induced neurotoxicity. We confirmed that primary mouse cortical neurons express all of the S1P receptor subtypes and FTY720-P directly affects the neurons. Treatment with FTY720-P enhanced the expression of brain-derived neurotrophic factor (BDNF) in neurons. Moreover, blocking BDNF-TrkB signaling with a BDNF scavenger, TrkB inhibitor, or ERK1/2 inhibitor almost completely ablated these neuroprotective effects. These results suggested that the neuroprotective effects of FTY720-P are mediated by upregulated neuronal BDNF levels. Therefore, FTY720-P may be a promising therapeutic agent for neurodegenerative diseases, such as Alzheimer's disease.
登录
查看更多内容
影响因子:
4.8
作者:
Brinkmann, V;Davis, MD;Lynch, KR
通讯作者:
Lynch, KR
影响因子:
4.2
作者:
Kemppainen, Susanna;Rantamaki, Tomi;Tanila, Heikki
通讯作者:
Tanila, Heikki
影响因子:
5.2
作者:
Kimura, Atsushi;Ohmori, Tsukasa;Sakata, Yoichi
通讯作者:
Sakata, Yoichi
影响因子:
4.8
作者:
De Felice, Fernanda G.;Velasco, Pauline T.;Klein, William L.
通讯作者:
Klein, William L.
影响因子:
6
作者:
Doi, Yukiko;Mizuno, Tetsuya;Suzumura, Akio
通讯作者:
Suzumura, Akio